These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1455 related items for PubMed ID: 8763848
1. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay. Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Takahashi M, Abe M. Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848 [Abstract] [Full Text] [Related]
2. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K. Anticancer Res; 2006 Jul; 26(2A):1261-70. PubMed ID: 16619533 [Abstract] [Full Text] [Related]
3. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines. Zhang M, Stevens G. Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413 [Abstract] [Full Text] [Related]
4. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation. Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Abe M. Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056 [Abstract] [Full Text] [Related]
5. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia. Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y. Radiat Med; 1998 Jan; 16(6):441-8. PubMed ID: 9929144 [Abstract] [Full Text] [Related]
6. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine. Hicks KO, Myint H, Patterson AV, Pruijn FB, Siim BG, Patel K, Wilson WR. Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):560-71. PubMed ID: 17869669 [Abstract] [Full Text] [Related]
7. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. Int J Hyperthermia; 2005 Jun 01; 21(4):305-18. PubMed ID: 16019857 [Abstract] [Full Text] [Related]
8. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents]. Jeremić B, Sibamoto J, Abe M. Srp Arh Celok Lek; 1996 Jun 01; 124(7-8):169-74. PubMed ID: 9102841 [Abstract] [Full Text] [Related]
9. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Korbelik M, Skov KA. Radiat Res; 1989 Jul 01; 119(1):145-56. PubMed ID: 2756105 [Abstract] [Full Text] [Related]
10. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay. Shibamoto Y, Streffer C, Sasai K, Oya N, Abe M. Int J Radiat Biol; 1992 Apr 01; 61(4):473-8. PubMed ID: 1349329 [Abstract] [Full Text] [Related]
11. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR, Brown JM. Radiat Res; 1993 Feb 01; 133(2):252-6. PubMed ID: 8438067 [Abstract] [Full Text] [Related]
12. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation. el-Said A, Menke D, Dorie MJ, Brown JM. Radiat Oncol Investig; 1999 Feb 01; 7(3):163-9. PubMed ID: 10406058 [Abstract] [Full Text] [Related]
13. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. Siim BG, Menke DR, Dorie MJ, Brown JM. Cancer Res; 1997 Jul 15; 57(14):2922-8. PubMed ID: 9230202 [Abstract] [Full Text] [Related]
14. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments. Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y. Radiat Med; 1999 Jul 15; 17(4):259-64. PubMed ID: 10510897 [Abstract] [Full Text] [Related]
15. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors. Masunaga S, Ono K, Akaboshi M, Takagaki M, Kinashi Y, Suzuki M, Abe M. Radiat Med; 1997 Jul 15; 15(1):37-43. PubMed ID: 9134583 [Abstract] [Full Text] [Related]
16. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells. Masunaga S, Nagasawa H, Uto Y, Hori H, Ohnishi K, Takahashi A, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K. Oncol Rep; 2005 Aug 15; 14(2):393-400. PubMed ID: 16012721 [Abstract] [Full Text] [Related]
17. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Yuan X, Tabassi K, Williams JA. Radiat Oncol Investig; 1999 Aug 15; 7(4):218-30. PubMed ID: 10492162 [Abstract] [Full Text] [Related]
18. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay. Masunaga S, Ono K, Hori H, Shibata T, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M. Jpn J Cancer Res; 1997 Sep 15; 88(9):907-14. PubMed ID: 9369940 [Abstract] [Full Text] [Related]
19. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine. Hay MP, Pruijn FB, Gamage SA, Liyanage HD, Kovacs MS, Patterson AV, Wilson WR, Brown JM, Denny WA. J Med Chem; 2004 Jan 15; 47(2):475-88. PubMed ID: 14711317 [Abstract] [Full Text] [Related]
20. Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice. Cardinale RM, Dillehay LE, Williams JA, Tabassi K, Brem H, Lee DJ. Radiat Oncol Investig; 1998 Jan 15; 6(2):63-70. PubMed ID: 9572682 [Abstract] [Full Text] [Related] Page: [Next] [New Search]